509 related articles for article (PubMed ID: 26800187)
1. Recent pharmacological developments in the treatment of perennial and persistent allergic rhinitis.
Klimek L; Mullol J; Hellings P; Gevaert P; Mösges R; Fokkens W
Expert Opin Pharmacother; 2016; 17(5):657-69. PubMed ID: 26800187
[TBL] [Abstract][Full Text] [Related]
2. Intranasal spray medications for maintenance therapy of allergic rhinitis.
Berger WE; Meltzer EO
Am J Rhinol Allergy; 2015; 29(4):273-82. PubMed ID: 26132312
[TBL] [Abstract][Full Text] [Related]
3. Advances in pharmacotherapy for the treatment of allergic rhinitis; MP29-02 (a novel formulation of azelastine hydrochloride and fluticasone propionate in an advanced delivery system) fills the gaps.
Bousquet J; Bachert C; Bernstein J; Canonica GW; Carr W; Dahl R; Demoly P; Devillier P; Hellings P; Fokkens W; Klimek L; Lieberman P; Meltzer E; Price D; Ryan D; Wahn U
Expert Opin Pharmacother; 2015 Apr; 16(6):913-28. PubMed ID: 25747125
[TBL] [Abstract][Full Text] [Related]
4. MP-AzeFlu provides rapid and effective allergic rhinitis control: results of a non-interventional study in Denmark.
Haahr PA; Jacobsen C; Christensen ME
Int Forum Allergy Rhinol; 2019 Apr; 9(4):388-395. PubMed ID: 30659752
[TBL] [Abstract][Full Text] [Related]
5. Effectiveness of allergic rhinitis treatments in real-life with a focus on MP-AzeFlu.
Klimek L; Demoly P; Price D
Expert Rev Clin Pharmacol; 2016; 9(5):705-14. PubMed ID: 26839083
[TBL] [Abstract][Full Text] [Related]
6. A Comparison of Health Care Resource Utilization and Costs for Patients with Allergic Rhinitis on Single-Product or Free-Combination Therapy of Intranasal Steroids and Intranasal Antihistamines.
Harrow B; Sedaghat AR; Caldwell-Tarr A; Dufour R
J Manag Care Spec Pharm; 2016 Dec; 22(12):1426-1436. PubMed ID: 27882840
[TBL] [Abstract][Full Text] [Related]
7. MP-AzeFlu is more effective than fluticasone propionate for the treatment of allergic rhinitis in children.
Berger W; Bousquet J; Fox AT; Just J; Muraro A; Nieto A; Valovirta E; Wickman M; Wahn U
Allergy; 2016 Aug; 71(8):1219-22. PubMed ID: 27043452
[TBL] [Abstract][Full Text] [Related]
8. Multicentre, non-interventional study to assess the profile of patients with uncontrolled rhinitis prescribed a novel formulation of azelastine hydrochloride and fluticasone propionate in a single spray in routine clinical practice in the UK.
Scadding G; Price D; El-Shanawany T; Ahmed S; Ray J; Sargur R; Kumar N
BMJ Open; 2017 Apr; 7(4):e014777. PubMed ID: 28442578
[TBL] [Abstract][Full Text] [Related]
9. Managing rhinitis: Strategies for improved patient outcomes.
Carr WW; Nelson MR; Hadley JA
Allergy Asthma Proc; 2008; 29(4):349-57. PubMed ID: 18702880
[TBL] [Abstract][Full Text] [Related]
10. MP-AzeFlu in Moderate-to-Severe Allergic Rhinitis: A Literature Review.
Klimek L; Berger WE; Bousquet J; Keith PK; Smith P; Sole D; Scadding G; Kuhl HC; Nguyen DT; Kopietz F; Koltun A
Int Arch Allergy Immunol; 2021; 182(11):1026-1035. PubMed ID: 34082425
[TBL] [Abstract][Full Text] [Related]
11. An algorithm recommendation for the pharmacological management of allergic rhinitis in the UK: a consensus statement from an expert panel.
Lipworth B; Newton J; Ram B; Small I; Schwarze J
NPJ Prim Care Respir Med; 2017 Jan; 27(1):3. PubMed ID: 28115736
[TBL] [Abstract][Full Text] [Related]
12. Clinical practice guideline: Allergic rhinitis.
Seidman MD; Gurgel RK; Lin SY; Schwartz SR; Baroody FM; Bonner JR; Dawson DE; Dykewicz MS; Hackell JM; Han JK; Ishman SL; Krouse HJ; Malekzadeh S; Mims JW; Omole FS; Reddy WD; Wallace DV; Walsh SA; Warren BE; Wilson MN; Nnacheta LC;
Otolaryngol Head Neck Surg; 2015 Feb; 152(1 Suppl):S1-43. PubMed ID: 25644617
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of a Novel Intranasal Formulation of Azelastine Hydrochloride and Fluticasone Propionate, Delivered in a Single Spray, for the Treatment of Seasonal Allergic Rhinitis: Results from Russia.
Ilyina NI; Edin AS; Astafieva NG; Lopatin AS; Sidorenko IV; Ukhanova OP; Khanova FM
Int Arch Allergy Immunol; 2019; 178(3):255-263. PubMed ID: 30677766
[TBL] [Abstract][Full Text] [Related]
14. Pharmacotherapy of allergic rhinitis: current options and future perspectives.
Ridolo E; Montagni M; Melli V; Braido F; Incorvaia C; Canonica GW
Expert Opin Pharmacother; 2014 Jan; 15(1):73-83. PubMed ID: 24219793
[TBL] [Abstract][Full Text] [Related]
15. Real-life effectiveness of MP-AzeFlu in Irish patients with persistent allergic rhinitis, assessed by visual analogue scale and endoscopy.
Kaulsay R; Nguyen DT; Kuhl HC
Immun Inflamm Dis; 2018 Dec; 6(4):456-464. PubMed ID: 30306729
[TBL] [Abstract][Full Text] [Related]
16. Pharmacotherapy for allergic rhinitis.
Platt M
Int Forum Allergy Rhinol; 2014 Sep; 4 Suppl 2():S35-40. PubMed ID: 25182353
[TBL] [Abstract][Full Text] [Related]
17. Pharmacotherapy for allergic rhinitis.
Melvin TA; Patel AA
Otolaryngol Clin North Am; 2011 Jun; 44(3):727-39, x. PubMed ID: 21621057
[TBL] [Abstract][Full Text] [Related]
18. Safety evaluation of MP29-02 (a novel intranasal formulation of azelastine hydrochloride and fluticasone propionate) for allergic rhinitis.
Klimek L; Bousquet J; Price D
Expert Opin Drug Saf; 2016 Jan; 15(1):117-29. PubMed ID: 26581312
[TBL] [Abstract][Full Text] [Related]
19. Real-Life Effectiveness of MP-AzeFlu (Dymista
Stjärne P; Nguyen DT; Kuhl HC
Pragmat Obs Res; 2023; 14():1-11. PubMed ID: 36628265
[TBL] [Abstract][Full Text] [Related]
20. Current therapeutical strategies for allergic rhinitis.
Klimek L; Sperl A; Becker S; Mösges R; Tomazic PV
Expert Opin Pharmacother; 2019 Jan; 20(1):83-89. PubMed ID: 30439290
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
